Scienture Inc. (SCNX)
0.91
0.03 (3.41%)
At close: Apr 15, 2025, 3:59 PM
0.90
-0.54%
After-hours: Apr 15, 2025, 06:23 PM EDT
3.41% (1D)
| Bid | 0.83 |
| Market Cap | 11.33M |
| Revenue (ttm) | 136.64K |
| Net Income (ttm) | 9.07M |
| EPS (ttm) | -5.41 |
| PE Ratio (ttm) | -0.17 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.92 |
| Volume | 128,151 |
| Avg. Volume (20D) | 2,886,222 |
| Open | 0.88 |
| Previous Close | 0.88 |
| Day's Range | 0.87 - 0.98 |
| 52-Week Range | 0.69 - 23.77 |
| Beta | 2.72 |
About SCNX
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida....
Sector Healthcare
IPO Date Feb 6, 2014
Employees 14
Stock Exchange NASDAQ
Ticker Symbol SCNX
Website https://www.trxadehealth.com
4 weeks ago
+19.5%
Scienture Holdings shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+9.55%
Scienture shares are trading higher after the company partnered with Kindeva to launch the 10mg REZENOPY nasal spray for opioid overdose treatment.